A recent study suggests that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro may regain lost weight at a significantly accelerated pace than those who halt traditional lifestyle plans.
Findings released in a major health publication shows that while obese people can lose substantial amounts of their total mass while on the medication, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Individuals buying these treatments should be cognizant of the danger of fast rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
Such speed of regain suggests a reversion to starting mass in about a year and a half.
Analyzing Therapies
The research, which reviewed 37 of trials involving over 9,000 of patients, compared the outcomes of GLP-1 agonists with older methods.
The team emphasize that people who lose weight through lifestyle changes alone usually have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Experts suggest the mode of action of the jabs is key to understanding the accelerated weight return.
The injections copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Stopping of this medication leads to appetite is uncontrolled, making excessive eating far more likely."
A Lifelong Condition?
Health authorities recommend the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Professionals argue that, due to the high risk of weight regain, the therapy should be considered ongoing.
This perspective is supported by pharmaceutical companies, who say that the results "underscore the persistent nature of excess weight," similar to managing conditions like high blood pressure.
User Accounts
People who have stopped the medication report a intense resurgence of appetite.
"It was like something activating and I was suddenly extremely hungry," recalled an individual.
The struggle is worsened if individuals have not established sustainable dietary or behavioural changes during therapy.
Significant Interest
Recent estimates show that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among females than men.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone cure and maintained weight loss relies on combined lifestyle support.
